Study guide
19.3 Epidemiology of Chronic Wounds
Certified Wound Specialist Physician CWSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the CWSP Exam
2 Chapter 1: Integumentary Anatomy & Wound Healing Biology
1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation
3 Chapter 2: Musculoskeletal & Neurologic Anatomy
2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care
4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing
3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing
5 Chapter 4: Patient Evaluation & Vascular Diagnostics
4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts
6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment
5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment
7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy
6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment
8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents
7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals
9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen
8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety
10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound
9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care
11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading
10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting
12 Chapter 11: Surgical Closure & Healing Complications
11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring
13 Chapter 12: Nutrition Therapy & Case Review
12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis
14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds
13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas
15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema
14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes
16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds
15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds
17 Chapter 16: Traumatic Wounds, Burns & Frostbite
16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite
18 Chapter 17: Surgical, Infectious & Pediatric Wounds
17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care
19 Chapter 18: Reimbursement, Regulation & Documentation
18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality
20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice
19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement
19.3 Epidemiology of Chronic Wounds
Key Takeaways Explain This Topic AI
Incidence counts new cases in a population at risk over a period of time, while prevalence counts all existing cases at a point in time (point prevalence) or over a period (period prevalence); for a stable condition, prevalence is approximately incidence multiplied by average duration.
Chronic wounds affected about 16.3% of Medicare beneficiaries (10.5 million people) in 2019, up from 14.5% (8.2 million) in 2014, according to Carter and colleagues.
The IDF Diabetes Atlas (11th edition, 2025) estimates 589 million adults aged 20 to 79 with diabetes worldwide, projected to reach 853 million by 2050, and the lifetime risk of a diabetic foot ulcer is about 19% to 34%.
Diabetic foot outcomes are serious: pooled 5-year mortality is about 30.5% after a diabetic foot ulcer, 46.2% after minor amputation, and 56.6% after major amputation, and most diabetes-related amputations are preceded by a foot ulcer.
Facility-acquired pressure injury rates are used as quality indicators, and the Agency for Healthcare Research and Quality has estimated that more than 2.5 million people in the United States develop pressure injuries each year.
Last updated: September 2026
19.3 Epidemiology of Chronic Wounds
Core Clinical Principle: Epidemiology tells wound specialists how common wounds are, who gets them, how often they recur, and what they cost. These numbers justify prevention programs, guide resource planning, and help patients understand the seriousness of conditions such as diabetic foot ulcers.
The CWSP outline lists epidemiology in Professional Issues. Research design and statistics used to evaluate treatments, such as relative risk and number needed to treat, are covered in the evidence-based practice section.
Measures of Disease Frequency
Measure Definition Wound Care Example
Incidence (cumulative) New cases during a period ÷ population at risk at the start New pressure injuries during a hospital stay ÷ patients admitted without one
Incidence rate (density) New cases ÷ total person-time at risk New pressure injuries per 1,000 patient-days
Point prevalence All existing cases at one time ÷ population at that time Patients with any pressure injury on survey day ÷ all patients surveyed
Period prevalence All cases existing at any time during a period ÷ average population Patients with a venous leg ulcer during a year
Facility-acquired prevalence Existing cases that developed after admission ÷ patients surveyed Hospital-acquired pressure injuries on survey day
Recurrence rate Healed wounds that reopen within a set time ÷ healed wounds Diabetic foot ulcers recurring within 1 year
Relationship: For a condition in steady state, prevalence ≈ incidence × average duration . A treatment that shortens healing time lowers prevalence even if incidence stays the same, while a treatment that keeps people alive longer with chronic wounds can raise prevalence.
Worked example: A 40-bed unit admits 200 patients without pressure injuries in a month, and 6 develop new injuries. Cumulative incidence is 6 ÷ 200 = 3% . On a single survey day, 5 of 38 patients have a pressure injury of any origin: point prevalence is 5 ÷ 38 ≈ 13% .
Other Useful Concepts
Crude versus age-adjusted rates: Adjusting allows fair comparison between populations with different age structures.
Risk factors, confounding, and bias: Observational data can suggest associations (for example, smoking and poor healing) but may be confounded by other factors.
Study designs: Cross-sectional surveys measure prevalence, cohort studies measure incidence and risk, and case-control studies compare exposures in people with and without a condition.
Surveillance and benchmarking: Standardized definitions and repeated measurement let facilities compare their rates over time and against peers.
The Burden of Chronic Wounds
- Statistic Value Source
- Medicare beneficiaries with a chronic wound, 2014 14.5% (8.2 million) Nussbaum and colleagues, 2018
- Medicare beneficiaries with a chronic wound, 2019 16.3% (10.5 million) Carter and colleagues, 2023
Adults aged 20–79 with diabetes worldwide, 2024 589 million (11.1%); projected 853 million by 2050 IDF Diabetes Atlas, 11th edition (2025)
People with diabetes in the United States, 2021 38.4 million (11.6% of the population) CDC National Diabetes Statistics Report
Lifetime risk of diabetic foot ulcer About 19% to 34% Armstrong, Boulton, and Bus, 2017
Diabetic foot ulcer recurrence About 40% within 1 year, about 60% within 3 years, about 65% within 5 years Armstrong, Boulton, and Bus, 2017
Diabetes-related amputations preceded by a foot ulcer About 84% Pecoraro and colleagues, 1990
Pooled 5-year mortality Diabetic foot ulcer 30.5%; Charcot 29.0%; minor amputation 46.2%; major amputation 56.6% Armstrong and colleagues, 2020
- People in the United States who develop pressure injuries each year More than 2.5 million AHRQ
- Global deaths from burns each year About 180,000 World Health Organization
- Venous and Arterial Disease
Venous disease causes most leg ulcers (commonly estimated at about 70%), with high recurrence without long-term compression.
Peripheral artery disease affects more than 200 million people worldwide, and many are undiagnosed because they have atypical or no symptoms. Chronic limb-threatening ischemia carries high amputation and mortality risk.
Mixed arterial and venous disease is common in older patients, which is why arterial screening before compression matters.
Pressure Injuries
Pressure injuries are common in hospitals, long-term care, and home care, and facility-acquired rates are tracked as quality indicators. In the United States, the Agency for Healthcare Research and Quality has estimated that more than 2.5 million people develop pressure injuries each year. Hospital-acquired stage 3 and 4 injuries affect payment through CMS hospital-acquired condition policies.
Disparities
Rates of diabetes-related amputation are higher among Black, Hispanic, and American Indian and Alaska Native populations and in rural and low-income communities in the United States, reflecting differences in access to preventive foot care, vascular evaluation, and specialty referral. Recognizing these patterns supports targeted screening, outreach, and multidisciplinary limb preservation programs.
Using Epidemiology in Practice
Plan services: Estimate how many patients with diabetes in a practice need high-risk foot care.
Measure quality: Track facility-acquired pressure injury incidence per 1,000 patient-days.
Counsel patients: Explaining that diabetic foot ulcers carry 5-year mortality comparable to many cancers helps patients understand why prevention matters.
Evaluate programs: Compare amputation or recurrence rates before and after a limb preservation program, adjusting for population changes.
- Clinical Traps
- Trap 1: Confusing Incidence With Prevalence
A survey-day count of existing pressure injuries is prevalence, not incidence. It includes injuries present on admission unless facility-acquired cases are separated.
Trap 2: Treating a Healed Diabetic Foot Ulcer as Cured
With about 40% recurrence in the first year, a healed foot is in remission and needs ongoing protective footwear and surveillance.